In addition to founder contributions, BrachyFoam has been fortunate to receive financial support in the form of grant funding from the National Cancer Institute and the Commonwealth Research Commercialization Fund:
- National Cancer Institute (NCI) Small Business Technology Transfer (STTR) Award (1R41CA203171-01A1): Self-expanding hydrogel for pelvic brachytherapy: a novel method for vaginal packing and customized radiation therapy.
- Awarded in 2017
- Commonwealth Research Commercialization Fund STTR Matching Award (STTR18-002-LS): Development and validation of delivery system for commercialization of self-expanding hydrogel for pelvic brachytherapy.
- Awarded in 2018
- National Cancer Institute (NCI) Small Business Technology Transfer (STTR) Award (2R42CA203171-02A1): Clinical validation and commercialization of a novel hydrogel-based vaginal packing system for pelvic brachytherapy.
- Awarded in 2019
BrachyFoam has a licensing agreement established with the University of Virginia Licensing & Ventures Group to develop a patented hydrogel technology developed by a collaborative team of researchers from UVA and Virginia Tech.